Improving cost-effectiveness analysis of childhood vaccines

Project Details

To review how equity and budgetary considerations have been taken into account within the cost-effectiveness literature on childhood vaccines.

PROJECT SUMMARY

Assessing the cost-effectiveness of new vaccines has been a priority area of research in recent years, yet most cost-effectiveness analyses fail to adequately address the distributional dimensions and equity implications of incorporating new vaccines within national immunisation schedules. Furthermore, in addition to incremental cost-effectiveness ratios, information on the budgetary impact of new vaccines is also essential for policy-makers. This project aims to provide an improved understanding of the economic and distributional impacts of the changing profile of childhood vaccines over the next decade, and contribute to the discussion on financing for policies aimed at reducing inequalities and improving the health of marginalised populations.

Researchers

Dr Natalie Carvalho

Funding

University of Melbourne

Research Group

Health Economics



Faculty Research Themes

Infection and Immunology, Child Health

School Research Themes

Data science, health metrics and disease modeling



Key Contact

For further information about this research, please contact the research group leader.

Department / Centre

Centre for Health Policy

Unit / Centre

Health Economics